NEJM says many post MI patients without left ventricular systolic dysfunction or heart failure receive long term beta blockers despite limited supporting data, highlighting uncertainty in routine continuation.
SMART-DECISION: Patients who have had an MI and do not have left ventricular systolic dysfunction or heart failure often receive beta-blockers over the long term, but data supporting this practice are lacking.
This finding is one of many signals tracked across Healthcare. The live feed updates every few hours with new authority voices, debates, and emerging ideas.
← Back to Healthcare